Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype

Infection and Immunity

Volumn 80, Issue 4, 2012, Pages 1554-1562

  Johnson, James R ^a,b   Porter, Stephen B ^a   Zhanel, George ^c   Kuskowski, Michael A ^a,b   Denamur, Erick ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA; QUINOLONE DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; FIMBRIA; GENOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SEPSIS; SYNTHESIS; ANIMAL; BACTERIUM IDENTIFICATION; DRUG EFFECT; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FIMBRIAE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS;

EID: 84859962147     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06388-11     Document Type: Article

References (50)

1. Achtman M, et al. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.
2. Berg DE, Akopyants NS, Kersulyte D. 1994. Fingerprinting microbial genomes using the RAPD or AP-PCR method. Methods Mol. Cell. Biol. 5:13-24.
3. Blattner FR, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.
4. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
5. Clermont O, et al. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028.
6. Coque TM, et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
7. Dozois C, Johnson J. 2000. The place of P fimbriae in the emergence of Escherichia coli extraintestinal pathotypes. ASM News 66:262-263.
8. Ender PT, et al. 2009. Transmission of extended-spectrum beta-lactamaseproducing Escherichia coli (sequence type ST131) between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J. Clin. Microbiol. 47:3780 -3782.
9. Goluszko P, et al. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J. Clin. Invest. 99:1661-1672.
10. Huang S-H, Wan Z-S, Chen Y-H, Jong AY, Kim KS. 2001. Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression. J. Infect. Dis. 183:1071-1078.
11. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. 2010. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr. Infect. Dis. J. 29:474-475.
12. Johnson JR, Clabots C, Rosen H. 2006. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74:461- 468.
13. Johnson JR, et al. 2006. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J. Infect. Dis. 194:1141-1150.
14. Johnson JR, Delavari P, O'Bryan T. 2001. Escherichia coli O18:K1:H7 isolates from acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. J. Infect. Dis. 183:425-434.
15. Johnson JR, Johnson CE, Maslow JN. 1999. Clinical and bacteriologic correlates of the papG alleles among Escherichia coli strains from children with acute cystitis. Pediatr. Infect. Dis. J. 18:446-451.
16. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin. Infect. Dis. 51:286-294.
17. Johnson JR, et al. 2010. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients Antimicrob. Agents Chemother. 54:546-550.
18. Johnson JR, et al. 2008. Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J. Clin. Microbiol. 46:417- 422.
19. Johnson JR, Johnston B, Kuskowski MA, Nougayrede J-P, Oswald E. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 46:3906 -3911.
20. Johnson JR, Kuskowski M, Denamur E, Elion J, Picard B. 2000. Clonal origin, virulence factors, and virulence (letter and reply). Infect. Immun. 68:424-425.
21. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. 2004. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190: 1739-1744.
22. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. 2003. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759 -768.
23. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob. Agents Chemother. 53:2733-2739.
24. Johnson JR, et al. 2011. Global distribution and epidemiological associations of Escherichia coli clonal group A, 1998-2007. Emerg. Infect. Dis. 17:2001-2009.
25. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
26. Johnson JR, et al. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168.
27. Johnson JR, et al. Pulsed-field gel electrophoresis analysis of 579 Escherichia coli sequence type ST131 isolates (1967-2009) in relation to year, geography, ecological source, and antimicrobial resistance. Emerg. Infect. Dis., in press.
28. Johnson JR, O'Bryan TT. 2004. Detection of the Escherichia coli group 2 polysaccharide capsule synthesis gene kpsM by a rapid and specific PCRbased assay. J. Clin. Microbiol. 42:1773-1776.
29. Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. 2006. Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 8:1702-1713.
30. Johnson JR, Russo TA. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int. J. Med. Microbiol. 295: 383-404.
31. Johnson JR, et al. 1997. Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG. Infect. Immun. 65:2153-2159.
32. Kao J-S, Stucker DM, Warren JW, Mobley HLT. 1997. Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect. Immun. 65:2812-2820.
33. Leflon-Guibout V, et al. 2008. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 46:3900-3905.
34. Le Gall T, et al. 2007. Extraintestinal virulence is a coincidental byproduct of commensalism in B2 phylogenetic group Escherichia coli strains. Mol. Biol. Evol. 24:2373-2384.
35. Levert M, et al. 2010. Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections. PLoS pathog. 6:e1001125.
36. Lieberman TD, et al. 2011. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genet. 43:1275-1280.
37. Moreno E, et al. 2006. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol. Infect. 134:1015-1023.
38. Nicolas-Chanoine M-H, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
39. Olesen B, et al. 2009. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J. Clin. Microbiol. 47:1857-1862.
40. Owens RC, et al. 2011. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J. Clin. Microbiol. 49:3406 -3408.
41. Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316 -321.
42. Picard B, et al. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546-553.
43. Reeves PR, et al. 2011. Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS One 6:e26907.
44. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
45. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. 2001. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45:1402-1406.
46. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. 2004. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J. Infect. Dis. 190:2121-2128.
47. Stamm WE, et al. 1989. Urinary tract infections: from pathogenesis to treatment. J. Infect. Dis. 159:400-405.
48. Vigil KJ, et al. 2010. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin. Infect. Dis. 50:374 -380.
49. Vila J, et al. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis. 186:1039 -1042.
50. Weissman SJ, et al. 2007. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect. Immun. 75:3548 -3555.